Sangamo Therapeutics logo
Sangamo Therapeutics SGMO
$ 1.91 -2.6%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Sangamo Therapeutics EV/EBITDA Ratio 2011-2024 | SGMO

Annual EV/EBITDA Ratio Sangamo Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-6.78 -14.7 -7.63 -13.1 -28.9 -3.19 -7.69 -32.7 -42.3 -22.4 -4.26

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-3.19 -42.3 -16.7